Journal profile · Computer Science-Computer Science Applications
JMIR Diabetes
ISSN 2371-4379 · JMIR Publications Inc. · Canada
JMIR Diabetes: CAS Zone 3 · Medicine (2026 Xinrui edition); impact factor 2.9 (journal website); fully open access; APC about USD 1,985; median 179 days to acceptance (100 articles, last 24 months); 61 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
JMIR Diabetes is published by JMIR Publications Inc. and is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Mobile Health and mHealth Applications, Diabetes Management and Education and Diabetes Management and Research, together about 61% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
JMIR Diabetes (JD, ISSN 2371-4379) focuses on technologies, medical devices, apps, engineering, informatics and patient education for diabetes prevention, self-management, care, and cure, to help people with diabetes. JMIR Diabetes may consider papers that do not have a digital health component but represent a significant innovation for diabetes prevention and care. JMIR Diabetes publishes original research, viewpoints, and reviews (both literature reviews and medical device/technology/app reviews) covering, for example, wearable devices and trackers, mobile apps, glucose monitoring (including emerging technologies such as Google contact lens), medical devices for insulin and metabolic peptide delivery, closed loop systems and artificial pancreas, telemedicine, web-based diabetes education and elearning, innovations for patient self-management and "quantified self", diabetes-specific EHR improvements, clinical or consumer-focused software, diabetes epidemiology and surveillance, crowdsourcing and quantified self-based research data, new sensors and actuators to be applied to diabetes. As an Open Access journal, JMIR Diabetes is read by clinicians and patients alike and has (as all JMIR Publications journals) a focus on readable and applied science reporting the design and evaluation of health innovations and emerging technologies, as well as on diabetes prevention and epidemiology. Need help choosing a journal? Use our Journal Finder tool to find the perfect match for your manuscript. Get Started
From the journal's Aims & Scope
Research area (LetPub): Computer Science-Computer Science Applications
Editor-in-chief Proposals Theme IssuesPublisher website
Editorial board by country: 3 in mainland China (about 21%); most named United States 4, Mainland China 3, Singapore 3, United Kingdom 1, India 1 (14 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Mobile Health and mHealth ApplicationsHealth Professions24.2%
- Diabetes Management and EducationMedicine22.5%
- Diabetes Management and ResearchMedicine14.3%
- Digital Mental Health InterventionsPsychology4.5%
- Hyperglycemia and glycemic control in critically ill and hospitalized patientsMedicine3.9%
- Health Literacy and Information AccessibilityHealth Professions3.8%
- Physical Activity and HealthMedicine2.5%
- Electronic Health Records SystemsHealth Professions2.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Health Care Sciences & Services | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 2.9Publisher website ·
- CiteScore 2026-06
- 5LetPub ·
- CiteScore (publisher) 2025
- 5Publisher website ·
- SJR 2026-06
- 0.83LetPub ·
- SNIP 2026-06
- 0.98LetPub ·
- h-index
- 37OpenAlex ·
- i10-index
- 180OpenAlex ·
- 2-year mean citedness
- 2.62OpenAlex ·
- Self-citation rate
- 6.9%LetPub ·
- Share of gold OA articles
- 97.56%LetPub ·
Volume
- Articles per year
- 49LetPub ·
Articles by year OpenAlex count · 383 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 41 | 41 | 15 |
| 2025 | 61 | 61 | 124 |
| 2024 | 38 | 38 | 228 |
| 2023 | 36 | 36 | 422 |
| 2022 | 44 | 44 | 728 |
| 2021 | 47 | 47 | 830 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
179 daysMedian, submission to acceptance · P25–P75 115 days – 256 days
- Acceptance to online
- median 52 days (100 articles)
- Submission to online
- median 245 days
- Sample
- 100 articles with submission and acceptance dates (119 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Submission to publication (journal-reported)
- about 20 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,985 | Yes | CC BY | |
| OpenAlex | USD 1,873 | — | — | |
| LetPub | USD 1,985 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteAuthorship, Publication ethics, Peer review, Preprints
- Authorship
ORCID required for all authors at time of publication Model summary
JMIR Publications requires that all authors / coauthors have an ORCID (a unique researcher identifier) at the time of publication.
Source ↗Publisher website ·- Publication ethics
COPE guidance for misconduct Model summary
Scientific, research, or publication misconduct are subject to investigation according to COPE guidance.
Source ↗Publisher website ·- Peer review Preprints Open for Peer Review
No prior publication or simultaneous submission Model summary
2026-08-05 | Share on Bluesky Share on Twitter Share on Facebook Share on LinkedIn Randomized controlled trial of Momordica charantia and Channa striata in type 2 diabetes mellitus: effects on AGEs, insulin, and glycemic profile Open Peer Review Period: August 19, 2026 - October 14, 2026 Peer Review Me 2026-06-30 | Share on Bluesky Share on Twitter Share on Facebook Share on LinkedIn Foundation mo…
Source ↗Publisher website ·- Preprints Preprints Open for Peer Review
2026-08-05 | Share on Bluesky Share on Twitter Share on Facebook Share on LinkedIn Randomized controlled trial of Momordica charantia and Channa striata in type 2 diabetes mellitus: effects on AGEs, insulin, and glycemic profile Open Peer Review Period: August 19, 2026 - October 14, 2026 Peer Review Me 2026-06-30 | Share on Bluesky Share on Twitter Share on Facebook Share on LinkedIn Foundation mo…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- JMIR Publications Inc.
- Country or region
- Canada
- Language
- English
- ISSN
- 2371-4379
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about JMIR Diabetes
What CAS zone is JMIR Diabetes in?
In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JMIR Diabetes?
The journal's website gives an impact factor of 2.9 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 5, h-index 37.
How long does peer review take at JMIR Diabetes?
Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 179 days (interquartile range 115–256 days); authors report an average review time of about 16 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of JMIR Diabetes based?
Of the 14 board members whose country the journal's board page names, 3 (about 21%) are in mainland China; the countries named most often are United States (4), Mainland China (3) and Singapore (3). Counted from the institutions listed on the board page; for reference only.
Which databases index JMIR Diabetes?
According to LetPub and DOAJ records, JMIR Diabetes is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science and PMC; that list has not been checked against each database.
Is JMIR Diabetes open access, and what is the APC?
JMIR Diabetes is a fully open-access journal. APC about USD 1,985.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .